SCHEMBL26599261

SCHEMBL26599261

OCc1cccnc1C1(O)CCOCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.35
PDE10A Q9Y233 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
PDE2A O00408 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
OPRL1 P41146 2/20 0.33
P2RX7 Q99572 2/20 0.33
METAP2 P50579 1/20 0.33
PAX8 Q06710 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ADAMTS4 O75173 1/20 0.32
MMP2 P08253 1/20 0.32
MMP13 P45452 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30670230 1.00 KMT2A (0.37) KMT2AMEN1L3MBTL1PDE10ANPC1
SCHEMBL24251561 0.91 PDE2A (0.37) KMT2AMEN1L3MBTL1PDE10ANPC1
SCHEMBL30670274 0.91 PDE2A (0.37) KMT2AMEN1L3MBTL1PDE10ANPC1
SCHEMBL30670248 0.82 PDE2A (0.39) KMT2AMEN1L3MBTL1PDE10ANPC1
SCHEMBL26599210 0.82 PDE2A (0.39) KMT2AMEN1L3MBTL1PDE10ANPC1
SCHEMBL30558736 0.80 PDE2A (0.36) PDE10APDE2AADAMTS4MMP2MMP13
SCHEMBL25263069 0.80 PDE2A (0.36) PDE10APDE2AADAMTS4MMP2MMP13
SCHEMBL1587985 0.76 MEN1 (0.40) KMT2AMEN1LMNASMN1; SMN2OPRL1
SCHEMBL2515120 0.74 OPRL1 (0.56) KMT2AKDM4ELMNAGAAOPRL1
SCHEMBL12701930 0.69 POLB (0.48) MMP2MMP13OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339977-A1 SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND APPLICATION THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2023-10-26 US disclosed
US-20230339977-A1 SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND APPLICATION THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2023-10-26 US disclosed
CN-114075221-A Substituted heteroaryl compounds, compositions and uses thereof 广东东阳光药业有限公司 2022-02-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339977-A1 SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND APPLICATION THEREOF TYK2, JAK1, JAK3 KMT2A 732/4885MEN1 3940/4885L3MBTL1 3139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.